Wealthcare Advisory Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,438
| Closed | -$220K | – | 2098 |
|
|
2021
Q1 | $220K | Buy |
+1,438
| New | +$220K | 0.02% | 458 |
|
|
2020
Q2 | – | Sell |
-23
| Closed | -$2K | – | 1502 |
|
|
2020
Q1 | $2K | Buy |
23
+9
| +64% | +$783 | ﹤0.01% | 1345 |
|
|
2019
Q4 | $2K | Hold |
14
| – | – | ﹤0.01% | 1297 |
|
|
2019
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1323 |
|
|
2019
Q2 | $2K | Hold |
14
| – | – | ﹤0.01% | 1220 |
|
|
2019
Q1 | $2K | Hold |
14
| – | – | ﹤0.01% | 1125 |
|
|
2018
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1181 |
|
|
2018
Q3 | $2K | Hold |
14
| – | – | ﹤0.01% | 1147 |
|
|
2018
Q2 | $2K | Hold |
14
| – | – | ﹤0.01% | 1149 |
|
|
2018
Q1 | $2K | Sell |
14
-3
| -18% | -$429 | ﹤0.01% | 986 |
|
|
2017
Q4 | $2K | Buy |
17
+3
| +21% | +$353 | ﹤0.01% | 947 |
|
|
2017
Q3 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 787 |
|